Report Detail

Request for Sample of this report

Other Global Cancer Oncology Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4517074
    • |
  • 27 February, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Cancer Oncology Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cancer Oncology Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cancer Oncology Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cancer Oncology Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cancer Oncology Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cancer Oncology Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Oncology Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Oncology Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Devyser, Agendia, Illumina, Personal Genome Diagnostics and Veracyte, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cancer Oncology Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market segment by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Market segment by players, this report covers
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Oncology Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Oncology Testing, with revenue, gross margin and global market share of Cancer Oncology Testing from 2018 to 2023.
Chapter 3, the Cancer Oncology Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cancer Oncology Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Oncology Testing.
Chapter 13, to describe Cancer Oncology Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Oncology Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer Oncology Testing by Type
    • 1.3.1 Overview: Global Cancer Oncology Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cancer Oncology Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Fluorescence In Situ Hybridization
    • 1.3.4 Polymerase Chain Reaction
    • 1.3.5 Microarray Technology
    • 1.3.6 Serum Proteomics
    • 1.3.7 Nucleic Acid Sequencing
  • 1.4 Global Cancer Oncology Testing Market by Application
    • 1.4.1 Overview: Global Cancer Oncology Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Speciality Clinics
    • 1.4.4 Research Institutes
    • 1.4.5 Diagnostics Laboratories
    • 1.4.6 Biopharmaceutical Companies
  • 1.5 Global Cancer Oncology Testing Market Size & Forecast
  • 1.6 Global Cancer Oncology Testing Market Size and Forecast by Region
    • 1.6.1 Global Cancer Oncology Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cancer Oncology Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Cancer Oncology Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cancer Oncology Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cancer Oncology Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cancer Oncology Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cancer Oncology Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Devyser
    • 2.1.1 Devyser Details
    • 2.1.2 Devyser Major Business
    • 2.1.3 Devyser Cancer Oncology Testing Product and Solutions
    • 2.1.4 Devyser Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Devyser Recent Developments and Future Plans
  • 2.2 Agendia
    • 2.2.1 Agendia Details
    • 2.2.2 Agendia Major Business
    • 2.2.3 Agendia Cancer Oncology Testing Product and Solutions
    • 2.2.4 Agendia Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Agendia Recent Developments and Future Plans
  • 2.3 Illumina
    • 2.3.1 Illumina Details
    • 2.3.2 Illumina Major Business
    • 2.3.3 Illumina Cancer Oncology Testing Product and Solutions
    • 2.3.4 Illumina Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Illumina Recent Developments and Future Plans
  • 2.4 Personal Genome Diagnostics
    • 2.4.1 Personal Genome Diagnostics Details
    • 2.4.2 Personal Genome Diagnostics Major Business
    • 2.4.3 Personal Genome Diagnostics Cancer Oncology Testing Product and Solutions
    • 2.4.4 Personal Genome Diagnostics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Personal Genome Diagnostics Recent Developments and Future Plans
  • 2.5 Veracyte
    • 2.5.1 Veracyte Details
    • 2.5.2 Veracyte Major Business
    • 2.5.3 Veracyte Cancer Oncology Testing Product and Solutions
    • 2.5.4 Veracyte Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Veracyte Recent Developments and Future Plans
  • 2.6 Pacific Biosciences of California
    • 2.6.1 Pacific Biosciences of California Details
    • 2.6.2 Pacific Biosciences of California Major Business
    • 2.6.3 Pacific Biosciences of California Cancer Oncology Testing Product and Solutions
    • 2.6.4 Pacific Biosciences of California Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Pacific Biosciences of California Recent Developments and Future Plans
  • 2.7 Qiagen
    • 2.7.1 Qiagen Details
    • 2.7.2 Qiagen Major Business
    • 2.7.3 Qiagen Cancer Oncology Testing Product and Solutions
    • 2.7.4 Qiagen Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Qiagen Recent Developments and Future Plans
  • 2.8 Agilent Technologies
    • 2.8.1 Agilent Technologies Details
    • 2.8.2 Agilent Technologies Major Business
    • 2.8.3 Agilent Technologies Cancer Oncology Testing Product and Solutions
    • 2.8.4 Agilent Technologies Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Agilent Technologies Recent Developments and Future Plans
  • 2.9 Natera
    • 2.9.1 Natera Details
    • 2.9.2 Natera Major Business
    • 2.9.3 Natera Cancer Oncology Testing Product and Solutions
    • 2.9.4 Natera Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Natera Recent Developments and Future Plans
  • 2.10 Bio Rad Laboratories
    • 2.10.1 Bio Rad Laboratories Details
    • 2.10.2 Bio Rad Laboratories Major Business
    • 2.10.3 Bio Rad Laboratories Cancer Oncology Testing Product and Solutions
    • 2.10.4 Bio Rad Laboratories Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Bio Rad Laboratories Recent Developments and Future Plans
  • 2.11 Myriad Genetics
    • 2.11.1 Myriad Genetics Details
    • 2.11.2 Myriad Genetics Major Business
    • 2.11.3 Myriad Genetics Cancer Oncology Testing Product and Solutions
    • 2.11.4 Myriad Genetics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Myriad Genetics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer Oncology Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cancer Oncology Testing by Company Revenue
    • 3.2.2 Top 3 Cancer Oncology Testing Players Market Share in 2022
    • 3.2.3 Top 6 Cancer Oncology Testing Players Market Share in 2022
  • 3.3 Cancer Oncology Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer Oncology Testing Market: Region Footprint
    • 3.3.2 Cancer Oncology Testing Market: Company Product Type Footprint
    • 3.3.3 Cancer Oncology Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer Oncology Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cancer Oncology Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cancer Oncology Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cancer Oncology Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cancer Oncology Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Cancer Oncology Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Cancer Oncology Testing Market Size by Country
    • 6.3.1 North America Cancer Oncology Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cancer Oncology Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cancer Oncology Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Cancer Oncology Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Cancer Oncology Testing Market Size by Country
    • 7.3.1 Europe Cancer Oncology Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cancer Oncology Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Oncology Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cancer Oncology Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cancer Oncology Testing Market Size by Region
    • 8.3.1 Asia-Pacific Cancer Oncology Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cancer Oncology Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cancer Oncology Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Cancer Oncology Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Cancer Oncology Testing Market Size by Country
    • 9.3.1 South America Cancer Oncology Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cancer Oncology Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Oncology Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cancer Oncology Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cancer Oncology Testing Market Size by Country
    • 10.3.1 Middle East & Africa Cancer Oncology Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cancer Oncology Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cancer Oncology Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cancer Oncology Testing Market Drivers
  • 11.2 Cancer Oncology Testing Market Restraints
  • 11.3 Cancer Oncology Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Cancer Oncology Testing Industry Chain
  • 12.2 Cancer Oncology Testing Upstream Analysis
  • 12.3 Cancer Oncology Testing Midstream Analysis
  • 12.4 Cancer Oncology Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Oncology Testing. Industry analysis & Market Report on Cancer Oncology Testing is a syndicated market report, published as Global Cancer Oncology Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cancer Oncology Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo